Cardiomyocyte proliferation contributes to heart growth in young humans.

TitleCardiomyocyte proliferation contributes to heart growth in young humans.
Publication TypeJournal Article
Year of Publication2013
AuthorsMollova M, Bersell K, Walsh S, Savla J, Das LTanmoy, Park S-Y, Silberstein LE, Remedios CGDos, Graham D, Colan S, Kühn B
JournalProc Natl Acad Sci U S A
Volume110
Issue4
Pagination1446-51
Date Published2013 Jan 22
ISSN1091-6490
KeywordsAdolescent, Adult, Cell Cycle, Cell Enlargement, Cell Proliferation, Child, Child, Preschool, Female, Fibrosis, Heart, Humans, Infant, Infant, Newborn, Male, Middle Aged, Myocardium, Myocytes, Cardiac, Ploidies, Regeneration, Young Adult
Abstract

The human heart is believed to grow by enlargement but not proliferation of cardiomyocytes (heart muscle cells) during postnatal development. However, recent studies have shown that cardiomyocyte proliferation is a mechanism of cardiac growth and regeneration in animals. Combined with evidence for cardiomyocyte turnover in adult humans, this suggests that cardiomyocyte proliferation may play an unrecognized role during the period of developmental heart growth between birth and adolescence. We tested this hypothesis by examining the cellular growth mechanisms of the left ventricle on a set of healthy hearts from humans aged 0-59 y (n = 36). The percentages of cardiomyocytes in mitosis and cytokinesis were highest in infants, decreasing to low levels by 20 y. Although cardiomyocyte mitosis was detectable throughout life, cardiomyocyte cytokinesis was not evident after 20 y. Between the first year and 20 y of life, the number of cardiomyocytes in the left ventricle increased 3.4-fold, which was consistent with our predictions based on measured cardiomyocyte cell cycle activity. Our findings show that cardiomyocyte proliferation contributes to developmental heart growth in young humans. This suggests that children and adolescents may be able to regenerate myocardium, that abnormal cardiomyocyte proliferation may be involved in myocardial diseases that affect this population, and that these diseases might be treatable through stimulation of cardiomyocyte proliferation.

DOI10.1073/pnas.1214608110
Alternate JournalProc Natl Acad Sci U S A
PubMed ID23302686
PubMed Central IDPMC3557060
Grant ListK08 HL085143 / HL / NHLBI NIH HHS / United States
R01 HL106302 / HL / NHLBI NIH HHS / United States